← Browse by Condition
Medical Condition

brain tumor

Total Trials
7
Recruiting Now
7
Trial Phases
Phase 1, Phase 2, Phase 2, Phase 4

ClinicalMetric tracks all active clinical trials for brain tumor sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — brain tumor Clinical Trials

How many clinical trials are currently recruiting for brain tumor?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for brain tumor, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for brain tumor?
brain tumor research spans Phase 1 (1 trial), Phase 2 (2 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a brain tumor clinical trial?
Eligibility criteria for brain tumor trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
2
Phase 4
1
Top Sponsors
Mayo Clinic 2 trials
Essen Biotech 1 trial
Meyer Children's Hospital IRCCS 1 trial
Georgetown University 1 trial
Brigham and Women's Hospital 1 trial

Recruiting Clinical Trials

NCT06640582 Phase 1, Phase 2
Recruiting
TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
Enrollment
85 pts
Location
China
Sponsor
Essen Biotech
View Trial →
NCT07417085
Recruiting
MICRO-BRAIN 2024: Study on Pediatric Brain Tumors
Enrollment
100 pts
Location
Italy
Sponsor
Meyer Children's Hospital IRCC...
View Trial →
NCT07105358
Recruiting
Visual Plasticity Following Brain Lesions
Enrollment
30 pts
Location
United States
Sponsor
Georgetown University
View Trial →
NCT04899908 Phase 2
Recruiting
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
Enrollment
134 pts
Location
United States
Sponsor
Brigham and Women's Hospital
View Trial →
NCT05733312
Recruiting
Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption
Enrollment
6 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT05926336 Phase 4
Recruiting
The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action
Enrollment
1,316 pts
Location
Taiwan
Sponsor
Kaohsiung Medical University C...
View Trial →
NCT04692337
Recruiting
Ommaya Reservoir Placement for Brain Tumor Biomarker Access
Enrollment
100 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →

Related Conditions

brain metastases (2) brain cancer (2) lung cancer (2) glioma (1) gliomas malignant (1) glioblastoma (1) meningioma (1) microbiota (1) visual field defect (1) stroke (1) hemianopia (1) quadrantanopia (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology